KR102754527B1 - 광학 활성 화합물의 제조법 - Google Patents

광학 활성 화합물의 제조법 Download PDF

Info

Publication number
KR102754527B1
KR102754527B1 KR1020197038460A KR20197038460A KR102754527B1 KR 102754527 B1 KR102754527 B1 KR 102754527B1 KR 1020197038460 A KR1020197038460 A KR 1020197038460A KR 20197038460 A KR20197038460 A KR 20197038460A KR 102754527 B1 KR102754527 B1 KR 102754527B1
Authority
KR
South Korea
Prior art keywords
group
salt
acid
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197038460A
Other languages
English (en)
Korean (ko)
Other versions
KR20200013707A (ko
Inventor
사유리 히라노
요시유키 다케다
고지 나카모토
모토키 이케우치
마사토 기타야마
마사토시 야마다
쥰이치 가와카미
Original Assignee
데이 원 바이오파마슈티칼즈, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이 원 바이오파마슈티칼즈, 인크. filed Critical 데이 원 바이오파마슈티칼즈, 인크.
Publication of KR20200013707A publication Critical patent/KR20200013707A/ko
Application granted granted Critical
Publication of KR102754527B1 publication Critical patent/KR102754527B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020197038460A 2017-05-30 2018-05-29 광학 활성 화합물의 제조법 Active KR102754527B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017106280 2017-05-30
JPJP-P-2017-106280 2017-05-30
PCT/IB2018/053822 WO2018220533A2 (ja) 2017-05-30 2018-05-29 光学活性化合物の製造法

Publications (2)

Publication Number Publication Date
KR20200013707A KR20200013707A (ko) 2020-02-07
KR102754527B1 true KR102754527B1 (ko) 2025-01-14

Family

ID=64454503

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197038460A Active KR102754527B1 (ko) 2017-05-30 2018-05-29 광학 활성 화합물의 제조법

Country Status (12)

Country Link
US (2) US10988469B2 (https=)
EP (2) EP3632441B1 (https=)
JP (2) JP7102233B2 (https=)
KR (1) KR102754527B1 (https=)
CN (2) CN111032047B (https=)
AU (1) AU2018276192B2 (https=)
CA (1) CA3065683A1 (https=)
EA (1) EA039880B1 (https=)
ES (1) ES2986461T3 (https=)
IL (1) IL270983B (https=)
MX (1) MX391164B (https=)
WO (1) WO2018220533A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX391164B (es) 2017-05-30 2025-03-21 Dot Therapeutics 1 Inc Metodo para producir compuesto opticamente activo
CN113557227A (zh) * 2019-03-27 2021-10-26 协和医药化工股份有限公司 前列腺素的制造方法
AU2021376286A1 (en) * 2020-11-06 2023-06-22 Dana-Farber Cancer Institute, Inc. Raf inhibitor for treating low grade glioma
CN114685564B (zh) * 2020-12-27 2023-09-22 西北大学 新型亚磷酰胺配体及其合成方法和应用
EP4377296A1 (en) 2021-07-26 2024-06-05 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
CN117567388B (zh) * 2023-11-14 2024-04-16 济南悟通生物科技有限公司 一种2-乙酰基-5-噻唑甲酸的合成方法
WO2026028053A2 (en) 2024-07-27 2026-02-05 Assia Chemical Industries Ltd. Process for the preparation of tovorafenib
CN119241530B (zh) * 2024-09-20 2026-04-10 武汉九州钰民医药科技有限公司 一种Tovorafenib的药物合成工艺
CN119241529B (zh) * 2024-09-20 2026-04-10 武汉九州钰民医药科技有限公司 一种Tovorafenib的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764842B2 (en) * 2001-03-28 2004-07-20 Merck & Co., Inc. Enantioselective bioreduction for the preparation of integrin receptor antagonist intermediates
TW200303304A (en) * 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
US7754889B2 (en) * 2004-03-29 2010-07-13 Takasago International Corporation Optically active transition metal-diamine compound and process for producing optically active alcohol with the same
TWI345568B (en) * 2004-04-02 2011-07-21 Mitsubishi Tanabe Pharma Corp Tetrahydronaphthyridine derivatives and a process for preparing the same
AR067354A1 (es) * 2007-06-29 2009-10-07 Sunesis Pharmaceuticals Inc Compuestos utiles como inhibidores de la raf quinasa
EP2167497A2 (en) * 2007-06-29 2010-03-31 Sunesis Pharmaceuticals, Inc. Heterocyclic compounds useful as raf kinase inhibitors
MX351657B (es) * 2012-03-14 2017-10-23 Merck Sharp & Dohme Sales de alcaloide de cinchona bis-cuaternarias como catalizadores de transferencia de fase asimétrica.
CN107880075A (zh) 2012-03-28 2018-04-06 武田药品工业株式会社 铑催化剂和制备胺化合物的方法
TWI602803B (zh) * 2013-03-29 2017-10-21 第一三共股份有限公司 光學活性二胺衍生物之製造方法
WO2015178846A1 (en) * 2014-05-20 2015-11-26 Sp Process Development Ab Process for the preparation of chiral amines from prochiral ketones
JP6638363B2 (ja) 2015-12-11 2020-01-29 株式会社大林組 掘削装置および杭孔の拡径方法
CN105524111B (zh) * 2016-01-25 2017-10-27 西北农林科技大学 手性亚磷酰胺单齿配体及其合成方法与应用
MX391164B (es) 2017-05-30 2025-03-21 Dot Therapeutics 1 Inc Metodo para producir compuesto opticamente activo

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Advanced Synthesis& Catalysis, 2010, 제352권, 페이지 753-819*

Also Published As

Publication number Publication date
EP3632441A2 (en) 2020-04-08
JP7420865B2 (ja) 2024-01-23
MX391164B (es) 2025-03-21
IL270983B (en) 2022-03-01
US20210347769A1 (en) 2021-11-11
JP2018203733A (ja) 2018-12-27
EP4406609A3 (en) 2024-10-02
AU2018276192A1 (en) 2020-01-16
AU2018276192B2 (en) 2022-05-19
EP4406609A2 (en) 2024-07-31
US20200317659A1 (en) 2020-10-08
MX2019014256A (es) 2022-03-31
JP7102233B2 (ja) 2022-07-19
KR20200013707A (ko) 2020-02-07
CN117447464A (zh) 2024-01-26
EP3632441A4 (en) 2021-01-13
WO2018220533A3 (ja) 2019-02-28
ES2986461T3 (es) 2024-11-11
CN111032047A (zh) 2020-04-17
EA201992709A1 (ru) 2020-04-23
WO2018220533A2 (ja) 2018-12-06
CA3065683A1 (en) 2018-12-06
EP3632441C0 (en) 2024-07-17
CN111032047B (zh) 2023-10-27
BR112019025355A2 (pt) 2020-06-23
JP2022116043A (ja) 2022-08-09
US10988469B2 (en) 2021-04-27
EA039880B1 (ru) 2022-03-23
US12129249B2 (en) 2024-10-29
EP3632441B1 (en) 2024-07-17
IL270983A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
KR102754527B1 (ko) 광학 활성 화합물의 제조법
JP6531093B2 (ja) 含窒素複素環化合物
US11053188B2 (en) Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides
US20180079741A1 (en) Process for producing heterocyclic compound
HK40114634A (en) Method for producing optically active compound
HK40022701A (en) Method for producing optically active compound
BR112019025355B1 (pt) Métodos para a produção de compostos oticamente ativos, composto e forma oticamente ativa
HK40022701B (en) Method for producing optically active compound
WO2018159639A1 (ja) 複素環化合物の製造方法
JP6446034B2 (ja) 複素環化合物の製造法
JP2025100323A (ja) 新規な３置換ビニルスルホキシイミン誘導体、およびその製造方法、ならびにそれを用いる３置換アルケンの立体選択的な製造方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601